Is Welcure Drugs & Pharmaceuticals Ltd a good quality company?

MoneyWorks4Me analysed the past 10-year performance of Welcure Drugs & Pharmaceuticals Ltd and arrived at the following conclusion.

Is the current market price of Welcure Drugs & Pharmaceuticals Ltd a good price to buy it?

The 5-year analysis of Welcure Drugs & Pharmaceuticals Ltd's performance infers.

What is Welcure Drugs & Pharmaceuticals Ltd share price return in the past 10 years?

We analysed the performance of Welcure Drugs & Pharmaceuticals Ltd share prices over the last 10 years. Here is what we found out:

What is a Financial Track Record? How to read this chart in order to understand the data present here?

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance

Difference between Standalone Basis and Consolidated basis? Which method is preferred for Welcure Drugs & Pharmaceuticals Ltd

Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.

What is CAGR? What does CAGR table indicate for Welcure Drugs & Pharmaceuticals Ltd?

Compounded average growth rate (CAGR) measures the average annual growth rate compounded year-on-year over a period of time.

Welcure Drugs & Pharmaceuticals informs about board meeting

Welcure Drugs & Pharmaceuticals Ltd. | Trading | Healthcare | BSE: 524661 | NSE:

31 Dec 2016

Evaluate

Welcure Drugs & Pharmaceuticals has informed that the next meetings of the Audit Committee and the Board of Directors of the Company will be held on January 01, 2017 to take on record the un-audited financial results for the quarter ended on December 31, 2016.

The above information is a part of company’s filings submitted to BSE.

Related Welcure Drugs & Pharmaceuticals Ltd. Links:

Analysis

Reports

News

Stock Price

Sector News